Biotech EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines January 5, 2023
Biotech CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference January 5, 2023
Biotech STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Catalyst Biosciences, Inc. – CBIO January 4, 2023
Biotech CLASS ACTION UPDATE for EIGR, AFRM and SGLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders January 4, 2023
Biotech ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX January 4, 2023
Biotech Eiger BioPharmaceuticals Class Action Deadline: Submit Your Losses to Johnson Fistel January 4, 2023
Biotech Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma January 4, 2023
Biotech Cidara Therapeutics Nominates First Oncology Clinical Development Candidate from its Cloudbreak® Platform January 4, 2023
Search
biotech companies
January 5, 2023
January 5, 2023
January 5, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
